A Phase I Dose-Escalation Study of Regorafenib (BAY 73-4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors

MROSS Klaus; FROST Annette; STEINBILO Simone; HEDBOM Susanne; BUECHERT Martin; FASOL Ulrike; UNGER Clemens; KRAETZSCHMAR Joern; HEINIG Roland; BOIX Oliver; CHRISTENSEN Olaf

Art

J-GLOBAL ID：201302288005475005 Reference number：13A0002143

A Phase I Dose-Escalation Study of Regorafenib (BAY 73-4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors

進行性固形腫瘍患者における発癌性,血管新生性および間質性キナーゼ阻害剤としてのレゴラフェニブ(BAY 73-4506)の第I相用量漸増試験

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=13A0002143&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A0002143&from=J-GLOBAL&jstjournalNo=W1296A") }}

Author (11)： , , , , , , , , , ,
Material：
Volume： 18 Issue： 9 Page： 2658-2667 Publication year： May. 01, 2012
JST Material Number： W1296A ISSN： 1078-0432 Document type： Article
Country of issue： United States (USA) Language： ENGLISH (EN)

, , , , , , , , , ,

Return to Previous Page